Navigation Links
Body Shaping Fuels Growth of $5.2 Billion Global Medical Aesthetic Market

ALISO VIEJO, Calif., Aug. 4 /PRNewswire/ -- Over the next five years, new body shaping and skin tightening technologies will drive double-digit growth in the global aesthetic industry, according to the just-released Global Aesthetic Market V research report from Medical Insight, Inc.

The GAM V study, which is the only published report providing comprehensive and in-depth global analysis of the entire $5.2 billion aesthetic industry, describes in detail how these relatively new categories will play prominent roles in escalating industry sales, projected to reach $8.9 billion by 2012. Among highlights in the fifth edition of this semi-annual forecast:

-- Body Shaping, the larger of the two businesses, will grow from $384.5 million in global supplier sales to $809.6 million by 2012, for 22.7% annual growth;

-- Skin Tightening will expand from $110.7 million in equipment revenues to $206 million in 2012, reflecting 18.9% annual growth;

-- Energy-based devices will earn manufacturers more than $1.6 billion in 2012, growing by 6.3% per year from $1.1 billion in 2008 after a slight decline in early 2008.

"Although the aesthetic device industry experienced a contraction in the first two quarters of 2008 due to a weaker U.S. economy with reduced spending, the body shaping and skin tightening sectors will drive overall growth of 13% per year in the aesthetic market," said Michael Moretti, president of Medical Insight, Inc. and editor of the GAM V study. "These two sets of technologies address a major problem associated with aging that until now, has not been solved. Combined, these two segments will represent more than $9 billion in physician fees and over $1 billion in device sales revenues by 2012."

Public companies detailed in GAM V include Allergan, Bioform, Candela, Cutera, Cynosure, Medicis, Mentor, Obagi, Palomar, Syneron, Thermage and more than three dozen others, including the leading startup players.

GAM V provides critical information on every product and procedure segment of the medical aesthetic industry. For more information and to preview a table of contents and Executive Summary, visit

About Medical Insight, Inc.

Medical Insight, Inc. is the industry leader in syndicated and custom research for the aesthetic market. Under the leadership of Michael Moretti, Medical Insight Inc. has collected data for over 20 years on procedure volume, revenues, product sales, new product introductions, market forecasts and trends, delivering detailed analyses that are used by many of the industry's top decision makers.

Contact: Medical Insight, Inc.

Michael Moretti, 949/830-5409


SOURCE Medical Insight, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. New Generation Biofuels Set to Join Russell Microcap Index
2. NexGen Biofuels Ltd. Announces Plans to Replace its CFO With Local CFO
3. Performance Plants Establishes U.S. Biofuels Facility
4. Monsanto Company and Mendel Biotechnology Announce Cellulosic Biofuels Collaboration
5. Science Fuels DNA Testing Controversy with Prejudicial Misquote
6. Nova Biosource Fuels Expands Senior Executive Team
7. NexGen Biofuels Ltd. Announces Trading on OTC Bulletin Board
8. Nova Biosource Fuels Announces First Funding Under $41 Million Senior Secured Credit Facility
9. NexGen Biofuels Ltd. (Nasdaq: NXGN) Announces Receipt of Nasdaq Delisting Determination
10. Healthcare Technologies Ltd. Announces the Change of its Name to "NexGen Biofuels Ltd"
11. Healthcare Announced That an Overwhelming Majority of its Shareholders Approved the NexGen Biofuels Transaction
Post Your Comments:
(Date:11/25/2015)... , Nov. 25, 2015 /PRNewswire/ - Aeterna Zentaris Inc. ... its business and prospects remain fundamentally strong and ... (zoptarelin doxorubicin) recently received DSMB recommendation to continue ... following review of the final interim efficacy and ... Primary Endpoint in men with heavily pretreated castration- ...
(Date:11/25/2015)... ... November 25, 2015 , ... Jessica Richman and Zachary Apte, ... their initial angel funding process. Now, they are paying it forward to other ... stage investments in the microbiome space. In this, they join other successful ...
(Date:11/24/2015)... SAN DIEGO , Nov. 24, 2015 Halozyme Therapeutics, ... Jaffray Healthcare Conference in New York on ... Dr. Helen Torley , president and CEO, will provide a ... New York at 1:00 p.m. ET/10:00 a.m. ... communication and investor relations, will provide a corporate overview. --> ...
(Date:11/24/2015)... 24, 2015 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ:  AEZS) (TSX: ... behalf of the Toronto Stock Exchange, confirms that as ... no corporate developments that would cause the recent movements ... --> About Aeterna Zentaris Inc. ... --> Aeterna Zentaris is a specialty biopharmaceutical company ...
Breaking Biology Technology:
(Date:10/29/2015)... Oct. 29, 2015  The J. Craig Venter Institute ... "DNA Synthesis and Biosecurity: Lessons Learned and Options for ... Health and Human Services guidance for synthetic biology providers ... --> --> Synthetic ... the potential to pose unique biosecurity threats. It now ...
(Date:10/29/2015)... health pioneer, Joseph C. Kvedar , MD, describes ... wellness, and the business opportunities that arise from it ... Healthy Things . Long before health and wellness ... vice president, Connected Health, Partners HealthCare, was creating a ... the hospital or doctor,s office into the day-to-day lives ...
(Date:10/27/2015)... -- In the present market scenario, security is one ... verticals such as banking, healthcare, defense, electronic gadgets, and ... secure & simplified access control and growing rate of ... bank accounts, misuse of users, , and so on. ... and smartphones are expected to provide potential opportunities for ...
Breaking Biology News(10 mins):